Further studies designed to separate platelet-CD4+ T cell aggregates ex vivo may provide insights into the mechanisms of platelet-CD4+ T cell aggregate permissiveness and disease progression in HIV-1 infection. This evidence concerns the gene CD4 and HIV-1 infection.